Drug Trial Radar · NCT03207672
Study of E7389 Liposomal Formulation in Participants With Solid Tumor
Last checked: Nov 19, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
140
Planned (sponsor's estimate)
Start
Aug 18, 2017
Primary completion
Jul 19, 2018
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- Eisai Co., Ltd.Eisai
- Sponsor type
- Industry
- First posted
- Jul 5, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The maximum tolerated dose (MTD) of E7389 liposomal formulation (E7389-LF) will be determined in the dose escalation part. Safety, pharmacokinetics (PK) and efficacy will be assessed using treatment regimen evaluated in dose escalation part in participants with breast cancer (up to 3 prior regimens of chemotherapy) in the expansion part 1 and in participants with adenoid cystic carcinoma (ACC), gastric cancer (GC), esophageal cancer (EGC), small cell lung cancer (SCLC) and breast cancer (with no prior regimens of chemotherapy) in the expansion part 2, 3, 4, 5 and 6 respectively.
Conditions
- Solid Tumor
Interventions
E7389-LFDrug
intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum tolerated dose (MTD) of E7389 liposomal formulation (E7389-LF)Time frame: Cycle 1 (21 days): Schedule 1; Cycle 1 (28 days): Schedule 2
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Eisai Trial Site 12
Fukuoka, Japan
Eisai Trial Site 11
Kyoto, Japan
Eisai Trial Site 2
Osaka, Japan
Eisai Trial Site 3
Kashiwa, Chiba, Japan
Eisai Trial Site 5
Sapporo, Hokkaido, Japan
Eisai Trial Site 8
Nishinomiya, Hyōgo, Japan
Eisai Trial Site 6
Yokohama, Kanagawa, Japan
Eisai Trial Site 10
Hidaka, Saitama, Japan
Eisai Trial Site 9
Bunkyo-ku, Tokyo, Japan
Eisai Trial Site 1
Chuo-ku, Tokyo, Japan
Eisai Trial Site 4
Koto-ku, Tokyo, Japan
Eisai Trial Site 7
Shinjuku-ku, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.